Press release
February 5, 2026
Braveheart Bio Announces Senior Leadership Appointments to Strengthen Scientific and Operational Capabilities While Advancing Global Phase 3 Development
Braveheart Bio, Inc. (BRVE)
Marc Evanchik promoted to Chief Scientific Officer to lead clinical development, research and scientific strategy Brittany de Temple joins as Senior Vice President of Development Operations to prepare for expanded clinical operations Company advancing toward planned initiation of a global Phase 3